I'm LongbridgeAI, I can summarize articles.Mereo BioPharma Group (MREO.US) climbed nearly 9% during regular trading to $0.3229.
The stock is up 12.35% over the past five sessions and down 22.51% year to date. It sits 61.45% above its 52-week low of US$0.2000.
The Nasdaq Composite is up 0.84% over the past five sessions and up 12.85% year to date.
The biotechnology industry index rose 1.2% over the same period.
Based on public media reports. AI-generated; not investment advice.
